• Palmer JP, Fleming GA, Greenbaum CJ, Herold KC, Jansa LD, Kolb H, et al. C-Peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve -cell function: report of an ADA workshop, 21-22 October 2001. Diabetes..
Relevance: 22.544956